However, the development and function of CCK+/CB1R+ INs has not been examined in mouse models that more broadly lack Dag1 throughout the CNS and thus more accurately reflect the neuropathology of dystroglycanopathy. This evidence concerns the gene DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.